Ratings Star Health and Allied Insurance Company Limited Bombay S.E.
Equities
STARHEALTH
INE575P01011
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
499.6 INR | +0.03% | -3.87% | -6.40% |
Apr. 30 | Transcript : Star Health and Allied Insurance Company Limited, Q4 2024 Earnings Call, Apr 30, 2024 | |
Apr. 30 | Star Health and Allied Insurance's Human Resources Chief to Retire in July | MT |
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 63% by 2026.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 33.88 times its estimated earnings per share for the ongoing year.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.40% | 3.5B | - | ||
+12.51% | 78.94B | B- | ||
+7.62% | 50.45B | B | ||
+5.93% | 49.81B | B+ | ||
+21.55% | 46.31B | B+ | ||
+24.52% | 39.83B | B | ||
-1.75% | 28.46B | B | ||
-8.98% | 27.07B | B- | ||
+27.21% | 26.32B | A | ||
-17.54% | 25.51B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- STARHEALTH Stock
- STARHEALTH Stock
- Ratings Star Health and Allied Insurance Company Limited